Dobutamine stress echo is superior to exercise stress testing in achieving target heart rate among patients on beta blockers

Cardiology

Volumn 104, Issue 3, 2005, Pages 138-142

  Sabbath, Adam ^a,b   Pack, Michael ^a   Markiewicz, Richard ^a   John, Jooby ^a   Gaballa, Mohamed ^a   Goldman, Steven ^a   Thai, Hoang ^a  

^a UNIVERSITY OF ARIZONA   (United States)

^b SOUTHERN ARIZONA VA HEALTH CARE SYSTEM   (United States)

Author keywords

Beta blocker; Dobutamine; Echo; Target; Treadmill

Indexed keywords

ATROPINE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DOBUTAMINE;

ADULT; AGED; ARTICLE; BETA ADRENERGIC RECEPTOR BLOCKING; CONTROLLED STUDY; DATA ANALYSIS; DIAGNOSTIC TEST; EXERCISE TEST; FEMALE; HEART RATE; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; STRESS ECHOCARDIOGRAPHY; TREADMILL EXERCISE;

ADRENERGIC BETA-ANTAGONISTS; AGED; COHORT STUDIES; CORONARY DISEASE; ECHOCARDIOGRAPHY, STRESS; EXERCISE TEST; FEMALE; HEART RATE; HUMANS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES;

EID: 24744445333     PISSN: 00086312     EISSN: None     Source Type: Journal    
DOI: 10.1159/000087634     Document Type: Article

References (19)

1. ACC/AHA Guidelines for Exercise Testing: Exercise testing to diagnose obstructive coronary artery disease. A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Exercise Testing). Circulation 2002;106:1883-1892.
2. Lee TH, Boucher CA: Clinical practice. Non-invasive tests in patients with stable coronary artery disease. N Engl J Med 2001;344:1840-1845.
3. Gauri A, Raxwal V, Roux L, Fearon W, Froelicher V: Effects of chronotropic incompetence and beta-blocker use on the exercise treadmill test in men. Am Heart J 2001;142:136-141.
4. Marcovitz P, Armstrong W: Impact of metoprolol on heart rate, blood pressure, and contractility in normal subjects during dobutamine stress echocardiography. Am J Cardiol 1997;80:386-388.
5. Ho S, McComish M, Taylor R: Effect of beta-adrenergic blockade on the results of exercise testing related to the extent of coronary artery disease. Am J Cardiol 1985;55:258-262.
6. Freemantle N, Cleland J, Young P, et al: β-Blockade after myocardial infarction: systematic review and meta-regression analysis. Br Med J 1999;318:1730.
7. Psaty BM, Koepsell TD, LoGerfo JP, et al: β-Blockers and primary prevention of coronary heart disease in patients with high blood pressure. JAMA 1989;261:2087.
8. Mangano DT, Layug EL, Wallace A, Tateo I: Effect of atenolol on mortality and cardiovascular morbidity after noncardiac surgery. N Engl J Med 1996;335:1713-1720.
9. Ferguson TB Jr, Coombs LP, Peterson ED: Perioperative beta-blocker use and mortality and morbidity following CABG surgery in North America. JAMA 2002;287:2221-2227.
10. Humma LM, Richardson HE, Lewis JF, McGorray SP, Pepine CJ, Johnson JA: Dobutamine pharmacodynamics during dobutamine stress echocardiography and the impact of beta-blocker withdrawal: a report from the Women's Ischemic Syndrome Evaluation Study. Pharmacotherapy 2002;22: 939-946.
11. Fletcher GF, Balady GJ, Amsterdam EA, et al: Exercise standards for testing and training: a statement for healthcare professionals from the American Heart Association. Circulation 2001;104:1694.
12. Sitges M, Pare C, Azqueta M, Bosch X, Miranda-Guardiola F, Velamazan M, et al: Feasibility and prognostic value of dobutamine stress echocardiography early in unstable angina. Eur Heart J 2000;21:1063-1071.
13. Ling LH, Pellikka PA, Mahoney DW, Mahoney DW, Oh JK, McCully RB, et al: Atropine augmentation in dobutamine stress echocardiography: role and incremental value in a clinical practice setting. J Am Coll Cardiol 1996;28:551-557.
14. Fioretti PM, Poldermans D, Salustri A, Forester T, Bellotti E, McNiell J, et al: Atropine increases the accuracy of dobutamine stress echocardiography in patients taking beta-blockers. Eur Heart J 1994;15:355-360.
15. Zaglavara T, Haaverstad R, Cumberledge B, Irvine T, Karvonuis H, Parharidis G, et al: Dobutamine stress echocardiography for the detection of myocardial viability in patients with left ventricular dysfunction taking beta-blockers: accuracy and optimal dose. Heart 2002;87:329-335.
16. Munagala VK, Guduguntla V, Kasravi B, Cummings G, Gardin JM: Use of atropine in patients with chronotropic incompetence and poor exercise capacity during treadmill stress testing. Am Heart J 2003;145:1046-1050.
17. Jost C, Pellikka P: Atropine for inconclusive exercise tests: a beautiful solution or just cosmetics? Am Heart J 2003;145:938-939.
18. Variola A, Albierto R, Dander B, et al: The exercise test with atropine. G Ital Cardiol 1997;27:255-262.
19. Diercks DB, Kirk JD, Turnipseed SD, Amsterdam EA: Utility of immediate exercise treadmill testing in patients taking beta-blockers or calcium channel blockers. Am J Cardiol 2002;90:882-885.